Abercrombie & Fitch (ANF.US) is one of the best performing US companies today. Stock rallies over 20% following release of fiscal-Q1 2025 earnings report (calendar February - April 2024) and trades at fresh all-time highs. Fiscal-Q1 2025 earnings turned out to be better-than-expected and upbeat guidance for fiscal-Q2 2025 and full-year fiscal-2025.
Abercrombie & Fitch results for fiscal-Q1 2025 turned out to be better than expected all across the board. Net sales grew over 22% and exceeded $1 billion, driven by strong over-30% growth in sales of Abercrombie brand. Meanwhile, cost of revenue climbed just 5.2%, paving the way for an over 500 basis point improvement in gross margin, compared to a year ago quarter. Operating and net margins also improved significantly, with net income jumping increasing over 470% year-over-year.
What drew even more attention than solid fiscal-Q1 earnings were new forecasts. Abercrombie expects net sales growth in 'mid-teens' in fiscal-Q2 as well as 10% growth in full fiscal-2025. Operating margin is seen at 13-14% in fiscal-Q2 and 'around 14%' in full-year. This means that the company not only expects strong sales growth to continue, but also expects further improvement in margins.
Fiscal-Q1 2025 earnings
- Net sales: $1.02 billion vs $0.96 billion expected (+22.1% YoY)
- Abercrombie: $571.5 million vs $526.5 million expected (+31.1% YoY)
- Hollister: $449.2 million vs $433.1 million expected (+12.3% YoY)
- Comparable sales: +21% vs +12.6% expected (+3% a year ago)
- Abercrombie: +29% vs +17% expected (+14% a year ago)
- Hollister: +13% vs +8.2% expected (-6% a year ago)
- Cost of revenue: $343.3 million vs $343.6 million expected (+5.2% YoY)
- Gross profit: $677.5 million vs $608.7 million expected (+32.9% YoY)
- Gross margin: 66.4% vs 64.4% expected (61.0% a year ago)
- Adjusted operating profit: $129.8 million vs $99.0 million expected (+237.8% YoY)
- Adjusted operating margin: 12.7% vs 9.4% expected (4.6% a year ago)
- Adjusted net income: $113.9 million vs $90.7 million (+474.4% YoY)
- Adjusted net margin: 11.2% vs 8.4% expected (2.4% a year ago)
- Adjusted diluted EPS: $2.14 vs $1.69 ($0.39 a year ago)
Fiscal-Q2 2025 forecast
- Net sales growth: 'up mid-teens' vs +8.5% expected
- Operating margin: 13-14%
Full-year fiscal-2025 forecast
- Net sales growth: 10%, up from previous guidance of 4-6%
- Operating margin: 'around 14%', up from previous guidance of 'around 12%'
- Capital expenditures: unchanged at 'about $170 million'
Source: xStation5
Daily wrap – US Export Restrictions on China and Weaker Earnings Trigger Wall Street Correction
Google Quantum Echoes – A Quantum Computing Breakthrough
Those Stocks Scared Investors Ahead Of This Halloween🎃 — Market Losers of 2025
IBM Earnings Preview: Will grandfather of IT industry deliver expectations?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.